+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Rhinitis- Epidemiology Forecast to 2032 - Product Thumbnail Image

Rhinitis- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pyoderma Gangrenosum - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pyoderma Gangrenosum - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hair Diseases - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hair Diseases - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute Graft-versus-host Disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

Acute Graft-versus-host Disease - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Allergic Fungal Rhinosinusitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Allergic Fungal Rhinosinusitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Allergy Sinus Pain - Epidemiology Forecast - 2032 - Product Thumbnail Image

Allergy Sinus Pain - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Autoimmune Encephalitis (AE) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Autoimmune Encephalitis (AE) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Autoimmune Gastritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Autoimmune Gastritis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Autophagy Modulators - Epidemiology Forecast - 2032 - Product Thumbnail Image

Autophagy Modulators - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
House Dust Mite Allergy - Epidemiology Forecast to 2032 - Product Thumbnail Image

House Dust Mite Allergy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Mastocytosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Mastocytosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Mucopolysaccharidosis I - Epidemiology Forecast to 2032 - Product Thumbnail Image

Mucopolysaccharidosis I - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Mucopolysaccharidosis II - Epidemiology Forecast to 2032 - Product Thumbnail Image

Mucopolysaccharidosis II - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Mucopolysaccharidosis III - Epidemiology Forecast to 2032 - Product Thumbnail Image

Mucopolysaccharidosis III - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HYQVIA - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

HYQVIA - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 30 Pages
  • Global
From
From
From
Graft Versus Host Disease (GvHD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Epidemiology Forecast - 2032

  • Report
  • August 2023
  • 102 Pages
  • Global
From
Pemphigus Vulgaris - Pipeline Insight, 2024 - Product Thumbnail Image

Pemphigus Vulgaris - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Celiac Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Celiac Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 115 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more